Ghate SR - Search Results

1

Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan.

Leith A, Ribbands A, Kim J, Clayton E, Gillespie-Akar L, Yang L, Ghate SR. Leith A, et al. Among authors: ghate sr. BMC Urol. 2022 Mar 11;22(1):33. doi: 10.1186/s12894-022-00979-9. BMC Urol. 2022. PMID: 35277153 Free PMC article.

2

Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.

Leith A, Ribbands A, Kim J, Last M, Barlow S, Yang L, Ghate SR. Leith A, et al. Among authors: ghate sr. Future Oncol. 2022 Mar;18(8):937-951. doi: 10.2217/fon-2021-1113. Epub 2022 Jan 19. Future Oncol. 2022. PMID: 35043687 Free article.

3

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan.

Leith A, Kim J, Ribbands A, Clayton E, Yang L, Ghate SR. Leith A, et al. Among authors: ghate sr. Adv Ther. 2022 May;39(5):2236-2255. doi: 10.1007/s12325-022-02073-w. Epub 2022 Mar 22. Adv Ther. 2022. PMID: 35316501 Free PMC article.

4

Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.

Shore N, Oliver L, Shui I, Gayle A, Wong OY, Kim J, Payne S, Amin S, Ghate S. Shore N, et al. J Urol. 2021 Apr;205(4):977-986. doi: 10.1097/JU.0000000000001570. Epub 2020 Dec 17. J Urol. 2021. PMID: 33332152

5

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors.

Shore ND, Laliberté F, Ionescu-Ittu R, Yang L, Mahendran M, Lejeune D, Yu LH, Burgents J, Duh MS, Ghate SR. Shore ND, et al. Among authors: ghate sr. Adv Ther. 2021 Aug;38(8):4520-4540. doi: 10.1007/s12325-021-01823-6. Epub 2021 Jul 19. Adv Ther. 2021. PMID: 34282527 Free PMC article.

6

Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.

Shore ND, Ionescu-Ittu R, Laliberté F, Yang L, Lejeune D, Yu L, Duh MS, Mahendran M, Kim J, Ghate SR. Shore ND, et al. Among authors: ghate sr. Clin Genitourin Cancer. 2021 Dec;19(6):480-490. doi: 10.1016/j.clgc.2021.07.009. Epub 2021 Jul 10. Clin Genitourin Cancer. 2021. PMID: 34373223 Free article.

7

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.

Shore N, Ionescu-Ittu R, Yang L, Laliberté F, Mahendran M, Lejeune D, Yu L, Burgents J, Duh MS, Ghate SR. Shore N, et al. Among authors: ghate sr. Future Oncol. 2021 Aug;17(22):2907-2921. doi: 10.2217/fon-2021-0153. Epub 2021 Apr 28. Future Oncol. 2021. PMID: 33906368 Free article.

8

Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Evans R, Hawkins N, Dequen-O'Byrne P, McCrea C, Muston D, Gresty C, Ghate SR, Fan L, Hettle R, Abrams KR, de Bono J, Hussain M, Agarwal N. Evans R, et al. Among authors: ghate sr. Target Oncol. 2021 Sep;16(5):613-623. doi: 10.1007/s11523-021-00837-y. Epub 2021 Sep 3. Target Oncol. 2021. PMID: 34478046 Free PMC article.

9

Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study.

Luke JJ, Ghate SR, Kish J, Lee CH, McAllister L, Mehta S, Ndife B, Feinberg BA. Luke JJ, et al. Among authors: ghate sr. Future Oncol. 2019 Sep 1;15(25):2933-2942. doi: 10.2217/fon-2018-0964. Epub 2019 Feb 25. Future Oncol. 2019. PMID: 30799646 Free article. Clinical Trial.

10

Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis.

Pal SK, Ghate SR, Li N, Swallow E, Peeples M, Zichlin ML, Perez JR, Agarwal N, Vogelzang NJ. Pal SK, et al. Among authors: ghate sr. Clin Genitourin Cancer. 2017 Aug;15(4):e573-e582. doi: 10.1016/j.clgc.2016.12.005. Epub 2017 Jan 5. Clin Genitourin Cancer. 2017. PMID: 28139444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page